Search research articles
Contact Us
Filters
Showing results (71-80 of 195) with videos related to
Page
of 20
Sort By:
Pharmacogenetics and Genomics
|
February 15, 2024
Attempted replication of pharmacogenetic association of variants in PPP1R14C and CCDC148 with aromatase inhibitor-induced musculoskeletal symptoms
Yuqing Liang, Christina L Gersch, Jennifer Lehman, et al.
Breast Cancer Research and Treatment
|
May 9, 2023
Breast cancer survivorship and sexual dysfunction: a population-based cohort study
Chun-Pin Chang, Tiffany F Ho, John Snyder, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
October 16, 2022
Simulation study comparing analytical methods for single-item longitudinal patient-reported outcomes data
Vinicius F Calsavara, Márcio A Diniz, Mourad Tighiouart, et al.
Cancer Research
|
May 4, 2019
A Multigene Assay Determines Risk of Recurrence in Patients with Triple-Negative Breast Cancer
Rachel L Stewart, Katherine L Updike, Rachel E Factor, et al.
Breast Cancer Research and Treatment
|
February 2, 2019
Factors influencing the use of extended adjuvant endocrine therapy
Kunal C Kadakia, Kelley M Kidwell, Debra L Barton, et al.
Journal of the National Cancer Institute
|
March 15, 2014
Promoting quality and evidence-based care in early-stage breast cancer follow-up
N Lynn Henry, Lynn N Henry, Daniel F Hayes, et al.
BMC Medical Research Methodology
|
November 10, 2021
Visualizing adverse events in clinical trials using correspondence analysis with R-package visae
Márcio A Diniz, Gillian Gresham, Sungjin Kim, et al.
Breast Cancer Research and Treatment
|
October 27, 2015
Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negative metastatic breast cancer refractory to a non-steroidal aromatase inhibitor
Kimberly Blackwell, Howard Burris, Patricia Gomez, et al.
Cancer
|
June 22, 2011
Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms
N Lynn Henry, Mousumi Banerjee, Max Wicha, et al.
Methodsx
|
June 3, 2026
Flow cytometry method to identify arginase-1 expressing MDSCs
Pugazhendhi Srinivasan, Misty Bechtel, Dorota Wyczechowska, et al.
Page
of 20
Search research articles
Search
Showing results (71-80 of 195) with videos related to
Sort By:
Page
of 20
Pharmacogenetics and Genomics
|
February 15, 2024
Attempted replication of pharmacogenetic association of variants in PPP1R14C and CCDC148 with aromatase inhibitor-induced musculoskeletal symptoms
Yuqing Liang, Christina L Gersch, Jennifer Lehman, et al.
Breast Cancer Research and Treatment
|
May 9, 2023
Breast cancer survivorship and sexual dysfunction: a population-based cohort study
Chun-Pin Chang, Tiffany F Ho, John Snyder, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
October 16, 2022
Simulation study comparing analytical methods for single-item longitudinal patient-reported outcomes data
Vinicius F Calsavara, Márcio A Diniz, Mourad Tighiouart, et al.
Cancer Research
|
May 4, 2019
A Multigene Assay Determines Risk of Recurrence in Patients with Triple-Negative Breast Cancer
Rachel L Stewart, Katherine L Updike, Rachel E Factor, et al.
Breast Cancer Research and Treatment
|
February 2, 2019
Factors influencing the use of extended adjuvant endocrine therapy
Kunal C Kadakia, Kelley M Kidwell, Debra L Barton, et al.
Journal of the National Cancer Institute
|
March 15, 2014
Promoting quality and evidence-based care in early-stage breast cancer follow-up
N Lynn Henry, Lynn N Henry, Daniel F Hayes, et al.
BMC Medical Research Methodology
|
November 10, 2021
Visualizing adverse events in clinical trials using correspondence analysis with R-package visae
Márcio A Diniz, Gillian Gresham, Sungjin Kim, et al.
Breast Cancer Research and Treatment
|
October 27, 2015
Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negative metastatic breast cancer refractory to a non-steroidal aromatase inhibitor
Kimberly Blackwell, Howard Burris, Patricia Gomez, et al.
Cancer
|
June 22, 2011
Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms
N Lynn Henry, Mousumi Banerjee, Max Wicha, et al.
Methodsx
|
June 3, 2026
Flow cytometry method to identify arginase-1 expressing MDSCs
Pugazhendhi Srinivasan, Misty Bechtel, Dorota Wyczechowska, et al.
Page
of 20